|
Volumn 103, Issue 5, 2001, Pages 638-642
|
Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS)
|
Author keywords
Cerebrovascular disorders; Hormones; Stroke
|
Indexed keywords
CONJUGATED ESTROGEN;
ESTROGEN;
GESTAGEN;
MEDROXYPROGESTERONE ACETATE;
PLACEBO;
ADULT;
AGE;
AGED;
ARTICLE;
BODY MASS;
CEREBROVASCULAR ACCIDENT;
CIGARETTE SMOKING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETES MELLITUS;
FEMALE;
FOLLOW UP;
HEART ATRIUM FIBRILLATION;
HORMONE SUBSTITUTION;
HUMAN;
HYPERTENSION;
INCIDENCE;
MAJOR CLINICAL STUDY;
MORTALITY;
POSTMENOPAUSE;
PRIORITY JOURNAL;
RACE DIFFERENCE;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
STROKE;
TRANSIENT ISCHEMIC ATTACK;
TREATMENT OUTCOME;
|
EID: 0035814748
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.CIR.103.5.638 Document Type: Article |
Times cited : (373)
|
References (33)
|